Skip to main content

Klompas Neil A's Form 4 filing

Zymeworks Inc.ZYME · filed Mar 14, 2023

Accession no.
0000899243-23-008432
Filed
Mar 14, 2023
Trade date
Mar 10, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $23.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Klompas Neil ACIK 0001761857Officer (President & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseAcquired+2,500$0.00F1$017,301Direct
Mar 10, 2023Common StockMOption exerciseAcquired+2,708$0.00F2$020,009Direct
Mar 10, 2023Common StockSSaleDisposed−2,977$7.83F4−$23,309.9117,032Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 10, 2023Common StockMOption exerciseDisposed−2,500$0.00$00Direct
Mar 10, 2023Common StockMOption exerciseDisposed−2,708$0.00$02,709Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.

Referenced by the price of 1 transaction in Table I.

F2

Represents shares of common stock issued upon vesting of one third of the RSUs granted on March 10, 2021.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.815 to $7.86, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)